Dr. Huan Vinh Dong is a Pediatric Infectious Disease Fellow at UCLA interested in molecular mechanisms of antimicrobial resistance. He holds a BA in Integrative Biology as well as in Theatre-Performance Studies from UC Berkeley, a MS in Nutrition from Columbia University, and MD from Charles Drew University/UCLA.

Jo-Anne Dillon's research interests include the antimicrobial susceptibility, molecular epidemiology and biology of Neisseria gonorrhoeae. She co-founded the WHO-GASP program and is currently the President of IUSTI. She is a Distinguished Professor at the University of Saskatchewan.

Liz Walker is an epidemiologist in the Epidemiology and Data Systems Branch, Health Protection, NSW Health. She hold a Master of Applied Epidemiology (FETP accredited) and MPH.

Zoïe Alexiou (MSc) is an STI Epidemiologist from the National Institute for Public Health in the Netherlands. Her research combines epidemiology, microbiology and immunogenetics to identify women with highest risk of Chlamydia related complications, alongside qualitative research that examines the impact of such tools on STI care.

Cheng Wang is the Vice President of the Dermatology Hospital at Southern Medical University, Associate Chief Physician, Master's Supervisor, Assistant Director of the Global Health Center at Southern Medical University, and Postdoctoral Fellow at North Carolina State University in the United States.

Nicola Low is an epidemiologist and public health specialist. Her research includes evaluation of screening interventions to prevent bacterial STIs and their complications, estimation of the burden of STIs, STIs in pregnancy, and diagnostics for antimicrobial-resistant STIs.

Haoyi Wang is an Epidemiologist and a PhD candidate with expertise in the related field of infectious disease epidemiology, public health and social psychology. His PhD focuses on the critical use of modelling in combination with social psychology science to facilitate ending the HIV pandemic by 2030.

Professor EdmondChoi is currently an Assistant Professor at the School of Nursing, The University of Hong Kong. He has received substantial grant awards and has an extensive publication record. He was recognized as one of the top 2% of the world's most-cited scientists in 2021 and 2022 by Stanford University.

Dr Samuel Adetona Fayemiwo is a Reader and Honorary Consultant Clinical Microbiologist at the Department of Medical Microbiology, College of Medicine, University of Ibadan, and University College Hospital, Ibadan, Nigeria. He works as an ID physician in the University College Hospital’s ARV Clinic, managing HIV/AIDS patients with sexually transmitted diseases.